![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Preview
When in rectal cancer surgery can the anal sphincter be spared? For which patients is iliac lymphadenectomy advisable? Should radiation therapy and chemotherapy be given before surgery rather than after? Drs Sexe and Miedema address these and other questions in this discussion of recent advances and future trends in therapy for rectal cancer.
Additional information
Notes on contributors
Robert Sexe
Robert Sexe, MD Brent W. Miedema, MD Dr Sexe is a resident in general surgery, Saint Louis University Medical Center, St Louis. Dr Miedema is assistant professor, department of surgery, University of Missouri—Columbia School of Medicine and Harry S Truman Memorial Veterans Affairs Medical Center, Columbia, Missouri; he is also codirector, endoscopy center, University of Missouri—Columbia School of Medicine. His research interests include gastrointestinal motility and treatment of gastrointestinal tumors.
Brent W. Miedema
Robert Sexe, MD Brent W. Miedema, MD Dr Sexe is a resident in general surgery, Saint Louis University Medical Center, St Louis. Dr Miedema is assistant professor, department of surgery, University of Missouri—Columbia School of Medicine and Harry S Truman Memorial Veterans Affairs Medical Center, Columbia, Missouri; he is also codirector, endoscopy center, University of Missouri—Columbia School of Medicine. His research interests include gastrointestinal motility and treatment of gastrointestinal tumors.